Literature DB >> 22884803

Modulation of the cannabinoid receptors by hemopressin peptides.

Martha G Bomar1, Amit K Galande.   

Abstract

Changes in the endocannabinoid system are implicated in numerous diseases, making it an attractive target for pharmaceutical development. The endocannabinoid receptors have traditionally been thought to act through the effects of lipophilic messengers called cannabinoids. The exciting finding of endocannabinoid system modulation by the nonapeptide hemopressin and its N-terminal extensions has highlighted the complexity of cannabinoid biology and pharmacology and sparked interest for therapeutic purposes. However, many questions surrounding the generation and regulation of the hemopressin peptides, the self-assembly of hemopressin and the potential for drug development based on hemopressin remain and are discussed in this review.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22884803      PMCID： PMC3594051          DOI： 10.1016/j.lfs.2012.07.028

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


  22 in total

1.  Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides.

Authors:  Lidija Covic; Amy L Gresser; Joyce Talavera; Steven Swift; Athan Kuliopulos
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

2.  Hemopressin forms self-assembled fibrillar nanostructures under physiologically relevant conditions.

Authors:  Martha G Bomar; Steven J Samuelsson; Patrick Kibler; Krishna Kodukula; Amit K Galande
Journal:  Biomacromolecules       Date:  2012-02-14       Impact factor: 6.988

Review 3.  The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.

Authors:  Didier M Lambert; Christopher J Fowler
Journal:  J Med Chem       Date:  2005-08-11       Impact factor: 7.446

Review 4.  CNS drug delivery: opioid peptides and the blood-brain barrier.

Authors:  Ken A Witt; Thomas P Davis
Journal:  AAPS J       Date:  2006-02-24       Impact factor: 4.009

5.  Hypotensive effects of hemopressin and bradykinin in rabbits, rats and mice. A comparative study.

Authors:  Paul-André Blais; Jérôme Côté; Josée Morin; Annie Larouche; Gabrielle Gendron; Audrey Fortier; Domenico Regoli; Witold Neugebauer; Fernand Gobeil
Journal:  Peptides       Date:  2005-04-26       Impact factor: 3.750

6.  Antinociceptive action of hemopressin in experimental hyperalgesia.

Authors:  Camila Squarzoni Dale; Rosana de Lima Pagano; Vanessa Rioli; Stephen Hyslop; Renata Giorgi; Emer Suavinho Ferro
Journal:  Peptides       Date:  2005-03       Impact factor: 3.750

7.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA.

Authors:  L A Matsuda; S J Lolait; M J Brownstein; A C Young; T I Bonner
Journal:  Nature       Date:  1990-08-09       Impact factor: 49.962

8.  Molecular characterization of a peripheral receptor for cannabinoids.

Authors:  S Munro; K L Thomas; M Abu-Shaar
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

9.  Preferential cleavage at aspartyl-prolyl peptide bonds in dilute acid.

Authors:  F Marcus
Journal:  Int J Pept Protein Res       Date:  1985-05

10.  Novel natural peptide substrates for endopeptidase 24.15, neurolysin, and angiotensin-converting enzyme.

Authors:  Vanessa Rioli; Fabio C Gozzo; Andrea S Heimann; Alessandra Linardi; José E Krieger; Cláudio S Shida; Paulo C Almeida; Stephen Hyslop; Marcos N Eberlin; Emer S Ferro
Journal:  J Biol Chem       Date:  2002-12-24       Impact factor: 5.157
View more
  7 in total

Review 1.  Mass Spectrometry Approaches Empowering Neuropeptide Discovery and Therapeutics.

Authors:  Krishna D B Anapindi; Elena V Romanova; James W Checco; Jonathan V Sweedler
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

Review 2.  The Endocannabinoid Signaling System in the CNS: A Primer.

Authors:  Cecilia J Hillard
Journal:  Int Rev Neurobiol       Date:  2015-11-06       Impact factor: 3.230

Review 3.  Cannabis and Cannabinoids in Reproduction and Fertility: Where We Stand.

Authors:  Bruno M Fonseca; Irene Rebelo
Journal:  Reprod Sci       Date:  2021-05-10       Impact factor: 2.924

4.  Disordered Peptides Looking for Their Native Environment: Structural Basis of CB1 Endocannabinoid Receptor Binding to Pepcans.

Authors:  Alessandro Emendato; Remo Guerrini; Erika Marzola; Hans Wienk; Rolf Boelens; Serena Leone; Delia Picone
Journal:  Front Mol Biosci       Date:  2018-11-16

Review 5.  Intracellular Peptides in Cell Biology and Pharmacology.

Authors:  Christiane B de Araujo; Andrea S Heimann; Ricardo A Remer; Lilian C Russo; Alison Colquhoun; Fábio L Forti; Emer S Ferro
Journal:  Biomolecules       Date:  2019-04-16

Review 6.  New Insights Into Peptide Cannabinoids: Structure, Biosynthesis and Signaling.

Authors:  Agustín Riquelme-Sandoval; Caio O de Sá-Ferreira; Leo M Miyakoshi; Cecilia Hedin-Pereira
Journal:  Front Pharmacol       Date:  2020-12-09       Impact factor: 5.810

7.  Modulation of subventricular zone oligodendrogenesis: a role for hemopressin?

Authors:  Sara Xapelli; Fabienne Agasse; Sofia Grade; Liliana Bernardino; Filipa F Ribeiro; Clarissa S Schitine; Andrea S Heimann; Emer S Ferro; Ana M Sebastião; Ricardo A De Melo Reis; João O Malva
Journal:  Front Cell Neurosci       Date:  2014-02-27       Impact factor: 5.505
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.